DLD Asset Management »

Cerevel Therapeutics Hldng I shares owned by DLD Asset Management

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by DLD Asset Management from 13F filings

Historical chart of DLD Asset Management investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by DLD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by DLD Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $698k 17k 42.27

More positions owned by DLD Asset Management

Cinemark Hldgs Note 4.500% 8/1 (Principal)
Sarepta Therapeutics DBCV 1.500%11/1 (Principal)
Zscaler Incorporated (ZS)
Ziff Davis Note 1.750%11/0 (Principal)
Starwood Ppty Tr Note 6.750% 7/1 (Principal)
Varex Imaging Corp Note 4.000% 6/0 (Principal)
Patrick Inds Note 1.750%12/0 (Principal)
Livent Corp Note 4.125% 7/1 (Principal)
Transocean Deb 4.625% 9/3 (Principal)
Middleby Corporation (MIDD)
Integer Hldgs Corp Note 2.125% 2/1 (Principal)
Tandem Diabetes Care Note 1.500% 5/0 (Principal)
Stride Note 1.125% 9/0 (Principal)
Ncl Corp Note 1.125% 2/1 (Principal)
Infinera Corp Note 3.750% 8/0 (Principal)

View all positions for DLD Asset Management

Top funds holding Cerevel Therapeutics Hldng I

Bain Capital Investors
Perceptive Advisors
Vanguard Group
BlackRock
State Street Corporation
Millennium Management
Alpine Associates Management
Paradigm Biocapital Advisors
Pentwater Capital Management
Soros Fund Management
LMR Partners
Marshall Wace
Alliancebernstein
Geode Capital Management
Citigroup

View all funds holding Cerevel Therapeutics Hldng I